Insider · CIK 0001527204
Diane Jorkasky
Files at ALT (Altimmune, Inc.). First filing Dec 29, 2025, latest Dec 29, 2025.
In brief
Diane Jorkasky files SEC Form 4 as director at ALT (Altimmune, Inc.). Since Dec 29, 2025, Diane Jorkasky has reported 1 open-market buy worth $2,003 and 0 open-market sells worth $0, the latest filed on Dec 29, 2025.
A track record needs three past buys with six months of prices behind them; Diane Jorkasky has 0, so none is measured yet.
The newest scored trade: bought $2,003 of ALT on Dec 29, 2025, filed Dec 29, 2025, scored 56 (moderate). In the last 12 months: 1 buy worth $2,003 and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ALT: Altimmune, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 56Moderate | Altimmune, Inc. | $2,003 527 shares | - | +9% from low-52% from high |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | ALT Altimmune, Inc. | AGrant or award Stock Options (option to buy)derivative | +48,800 | $0.00 | $0 | 48,800 | May 1, 2026 |
| Dec 29, 2025 | ALT Altimmune, Inc. | POpen-market purchase Common Stock, par value $0.0001 | +527 | $3.80 | $2,003 | 527 | Dec 29, 2025 |
| Sep 25, 2025 | ALT Altimmune, Inc. | AGrant or award Stock Options (option to buy)derivative | +48,800 | $0.00 | $0 | 48,800 | Sep 29, 2025 |
Questions about Diane Jorkasky
Answered from the filings on this page, as of the latest one.
Is Diane Jorkasky buying or selling?
In the last 12 months Diane Jorkasky reported 1 open-market buy worth $2,003 and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $2,003 of ALT on Dec 29, 2025. Grants, option exercises and tax withholding are not counted.
How did Diane Jorkasky's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Diane Jorkasky has 0.
Where does Diane Jorkasky file Form 4?
Diane Jorkasky has filed Form 4 at ALT (Altimmune, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.